FindTrial
Sign In

Research on the Pathogenesis of Eczema and the Diagnostic and Therapeutic Mechanisms of Uighur Medicine

Study on the Pathogenesis of Eczema and the Therapeutic Mechanisms of Uighur Medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000501
Enrollment
Unknown
Registered
2024-09-29
Start date
2023-12-15
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema.

Interventions

Uighur medicine treatment group:-
Uighur and Western medicine treatment group:-

Sponsors

Xinjiang Uyghur Autonomous Region Uyghur Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Meets the diagnostic criteria of Western medicine and traditional Uyghur medicine; (2)No use of glucocorticoids antihistamines or other topical medications in the 4 weeks prior to treatment; (3)No gender restriction age 18 to 65 years; (4)Patients with subacute and chronic eczema; (5)Signed informed consent and willingness to cooperate with treatment.

Exclusion criteria

Exclusion criteria: (1)Patients with severe cardiovascular pulmonary liver kidney gastrointestinal hematologic endocrine or psychiatric diseases; (2)Presence of fungal bacterial or viral infections at the affected site; (3)Pregnant or breastfeeding women; (4)Participants in other drug clinical trials within the past 1 month; (5)Exclude patients with acute eczema.

Design outcomes

Primary

MeasureTime frame
Extent and severity of eczema;—

Secondary

MeasureTime frame
Severity of itching score;"Dermatology Life Quality Index (DLQI);—

Countries

China

Contacts

Public ContactLi Zhi jian

Xinjiang Uyghur Autonomous Region Uyghur Medical Hospita Affiliation

lizhijian0220@sina.com15981799975

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026